Northern Trust
ELTX icon

Northern Trust’s Elicio Therapeutics ELTX Stock Holding History

Northern Trust’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Buy
130,162
+70,428
+118% +$707K ﹤0.01% 3665
2026
Q1 		$639K Buy
59,734
+6,965
+13% +$67.3K ﹤0.01% 3515
2025
Q4 		$420K Sell
52,769
-815
-2% -$7.4K ﹤0.01% 3718
2025
Q3 		$586K Buy
53,584
+2,584
+5% +$26.1K ﹤0.01% 3597
2025
Q2 		$394K Sell
51,000
-855
-2% -$5.32K ﹤0.01% 3728
2025
Q1 		$319K Buy
51,855
+21,086
+69% +$163K ﹤0.01% 3769
2024
Q4 		$157K Hold
30,769
– – ﹤0.01% 4054
2024
Q3 		$155K Buy
30,769
+19,589
+175% +$86.8K ﹤0.01% 3953
2024
Q2 		$46K Buy
+11,180
New +$94.6K ﹤0.01% 4223
2023
Q2 		– Sell
-3,379
Closed -$19.6K – 4549
2023
Q1 		$19.6K Hold
3,379
– – ﹤0.01% 4452
2022
Q4 		$27.4K Hold
3,379
– – ﹤0.01% 4417
2022
Q3 		$31K Buy
3,379
+1,673
+98% +$17.5K ﹤0.01% 4449
2022
Q2 		$20K Sell
1,706
-15,253
-90% -$244K ﹤0.01% 4623
2022
Q1 		$360K Sell
16,959
-807
-5% -$18.2K ﹤0.01% 3869
2021
Q4 		$515K Sell
17,766
-66
-0.4% -$3.34K ﹤0.01% 3806
2021
Q3 		$1.74M Buy
17,832
+11,379
+176% +$1.23M ﹤0.01% 3355
2021
Q2 		$839K Sell
6,453
-19
-0.3% -$2.74K ﹤0.01% 3567
2021
Q1 		$1.17M Buy
+6,472
New +$1.25M ﹤0.01% 3516

Other funds holding ELTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust's ELTX Position: Q2 2026 in Review

Northern Trust increased its Elicio Therapeutics (ELTX) stake by 118% in Q2 2026, buying an estimated $707K and bringing the position to 130,162 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #3665.

Northern Trust first reported a position in ELTX in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.74M in Q3 2021. 46 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Northern Trust held 130,162 shares of Elicio Therapeutics worth $509K as of Q2 2026.
  • Northern Trust bought 70,428 Elicio Therapeutics shares in Q2 2026, an estimated $707K.
  • Elicio Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3665 holding.
  • Northern Trust first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Northern Trust's Elicio Therapeutics position peaked at $1.74M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.